President & CEO MD
Claes Strom joined Pharmacosmos on 1 May 2010, initially as head of Pharmacosmos CRO, and later as Vice President, Marketing and Medical Affairs and on the 5th ofMarch 2018 Vice President, Affiliates & Medical Affairs. On the 20th of January 2022 he was appointed Vice President, CCO.
After graduating from Medical School, Claes worked for a number of years in Cardiology primarily at the Danish National Hospital where he also did his PhD. He went on to join the Pharmaceutical industry with GlaxoSmithKline working in different management roles in medical affairs and marketing. He then joined aCROnordic, one of the leading full service clinical CROs in the Nordic that was later acquired by Ecron Acunova, where he served as Director, Clinical Operations, Partner and finally COO before joining Pharmacosmos. In addition to his Medical Degree and PhD from University of Copenhagen he has a finance degree (HD) from Copenhagen Business School.
Aside from work, Claes enjoys traveling and doing sports, especially running.
You are now leaving Pharmacosmos.com. The website you are about to visit is is a Pharmacosmos subsidary. Do you want to proceed?